(ARE) Alexandria Real Estate - Ratings and Ratios
Office Space, Laboratory Space, Rental Income, Real Estate
ARE EPS (Earnings per Share)
ARE Revenue
Description: ARE Alexandria Real Estate
Alexandria Real Estate Equities Inc (NYSE:ARE) is a leading life science REIT with a proven track record of developing and operating high-quality, collaborative Megacampus ecosystems in top innovation clusters. With a strong presence in key locations such as Greater Boston, San Francisco Bay Area, and San Diego, the company has established itself as a pioneer in the life science real estate niche since its founding in 1994.
The companys asset base comprises 39.6 million RSF of operating properties and 4.0 million RSF of Class A/A+ properties under construction, with a total market capitalization of $28.8 billion as of March 31, 2025. Alexandrias business model is designed to drive long-term value creation through high-quality and diverse tenant base, resulting in higher occupancy levels, longer lease terms, and higher rental income.
From a financial perspective, key performance indicators (KPIs) such as Funds From Operations (FFO) and Adjusted Funds From Operations (AFFO) are crucial in evaluating the companys performance. Alexandrias FFO and AFFO growth rates, as well as its dividend yield and payout ratio, are important metrics to consider. Additionally, the companys debt-to-equity ratio and interest coverage ratio provide insight into its capital structure and ability to meet its financial obligations.
Alexandrias venture capital platform also provides strategic capital to transformative life science companies, further enhancing its position in the industry. With a strong focus on creating long-term value for shareholders, the companys commitment to delivering high-quality properties and services is reflected in its high occupancy rates and long-term lease agreements. As a member of the S&P 500, Alexandria is well-positioned to continue its growth trajectory and deliver strong returns to investors.
ARE Stock Overview
| Market Cap in USD | 14,498m |
| Sub-Industry | Diversified REITs |
| IPO / Inception | 1997-05-27 |
ARE Stock Ratings
| Growth Rating | -68.7% |
| Fundamental | 61.9% |
| Dividend Rating | 77.4% |
| Return 12m vs S&P 500 | -38.7% |
| Analyst Rating | 3.54 of 5 |
ARE Dividends
| Dividend Yield 12m | 7.41% |
| Yield on Cost 5y | 5.10% |
| Annual Growth 5y | 4.13% |
| Payout Consistency | 96.0% |
| Payout Ratio | 2.1% |
ARE Growth Ratios
| Growth Correlation 3m | 70.6% |
| Growth Correlation 12m | -82.8% |
| Growth Correlation 5y | -84.1% |
| CAGR 5y | -11.64% |
| CAGR/Max DD 3y | -0.21 |
| CAGR/Mean DD 3y | -0.41 |
| Sharpe Ratio 12m | -0.57 |
| Alpha | 0.00 |
| Beta | 0.959 |
| Volatility | 28.89% |
| Current Volume | 1143.3k |
| Average Volume 20d | 1139.4k |
| Stop Loss | 82.5 (-3.1%) |
| Signal | -0.64 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-12.8m TTM) > 0 and > 6% of Revenue (6% = 182.7m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 2.28pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -68.51% (prev -46.56%; Δ -21.95pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 1.42b > Net Income -12.8m (YES >=105%, WARN >=100%) |
| Net Debt (13.14b) to EBITDA (1.84b) ratio: 7.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (170.1m) change vs 12m ago -1.09% (target <= -2.0% for YES) |
| Gross Margin 69.63% (prev 70.41%; Δ -0.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 8.07% (prev 7.82%; Δ 0.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.56 (EBITDA TTM 1.84b / Interest Expense TTM 205.4m) >= 6 (WARN >= 3) |
Altman Z'' -0.05
| (A) -0.06 = (Total Current Assets 868.1m - Total Current Liabilities 2.95b) / Total Assets 37.62b |
| (B) 0.07 = Retained Earnings (Balance) 2.51b / Total Assets 37.62b |
| (C) 0.01 = EBIT TTM 526.7m / Avg Total Assets 37.74b |
| (D) -0.00 = Book Value of Equity -25.7m / Total Liabilities 15.88b |
| Total Rating: -0.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.91
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 5.21% = 2.60 |
| 3. FCF Margin 46.64% = 7.50 |
| 4. Debt/Equity 0.77 = 2.21 |
| 5. Debt/Ebitda 7.23 = -2.50 |
| 6. ROIC - WACC (= -3.78)% = -4.72 |
| 7. RoE -0.07% = -0.01 |
| 8. Rev. Trend 90.00% = 6.75 |
| 9. EPS Trend 31.47% = 1.57 |
What is the price of ARE shares?
Over the past week, the price has changed by +1.36%, over one month by +10.27%, over three months by +21.74% and over the past year by -27.36%.
Is Alexandria Real Estate a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ARE is around 82.35 USD . This means that ARE is currently overvalued and has a potential downside of -3.28%.
Is ARE a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 9
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ARE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 96.4 | 13.2% |
| Analysts Target Price | 96.4 | 13.2% |
| ValueRay Target Price | 89.1 | 4.6% |
Last update: 2025-09-15 04:30
ARE Fundamental Data Overview
CCE Cash And Equivalents = 520.5m USD (last quarter)
P/E Forward = 16.6945
P/S = 4.6797
P/B = 0.8441
P/EG = 844.2
Beta = 1.311
Revenue TTM = 3.04b USD
EBIT TTM = 526.7m USD
EBITDA TTM = 1.84b USD
Long Term Debt = 12.20b USD (from longTermDebt, last quarter)
Short Term Debt = 1.10b USD (from shortTermDebt, last quarter)
Debt = 13.29b USD (Calculated: Short Term 1.10b + Long Term 12.20b)
Net Debt = 13.14b USD (from netDebt column, last quarter)
Enterprise Value = 27.27b USD (14.50b + Debt 13.29b - CCE 520.5m)
Interest Coverage Ratio = 2.56 (Ebit TTM 526.7m / Interest Expense TTM 205.4m)
FCF Yield = 5.21% (FCF TTM 1.42b / Enterprise Value 27.27b)
FCF Margin = 46.64% (FCF TTM 1.42b / Revenue TTM 3.04b)
Net Margin = -0.42% (Net Income TTM -12.8m / Revenue TTM 3.04b)
Gross Margin = 69.63% ((Revenue TTM 3.04b - Cost of Revenue TTM 924.5m) / Revenue TTM)
Tobins Q-Ratio = -1061 (set to none) (Enterprise Value 27.27b / Book Value Of Equity -25.7m)
Interest Expense / Debt = 0.42% (Interest Expense 55.3m / Debt 13.29b)
Taxrate = 21.0% (US default)
NOPAT = 416.1m (EBIT 526.7m * (1 - 21.00%))
Current Ratio = 0.29 (Total Current Assets 868.1m / Total Current Liabilities 2.95b)
Debt / Equity = 0.77 (Debt 13.29b / last Quarter total Stockholder Equity 17.18b)
Debt / EBITDA = 7.23 (Net Debt 13.14b / EBITDA 1.84b)
Debt / FCF = 9.36 (Debt 13.29b / FCF TTM 1.42b)
Total Stockholder Equity = 17.69b (last 4 quarters mean)
RoA = -0.03% (Net Income -12.8m, Total Assets 37.62b )
RoE = -0.07% (Net Income TTM -12.8m / Total Stockholder Equity 17.69b)
RoCE = 1.76% (Ebit 526.7m / (Equity 17.69b + L.T.Debt 12.20b))
RoIC = 1.36% (NOPAT 416.1m / Invested Capital 30.52b)
WACC = 5.14% (E(14.50b)/V(27.79b) * Re(9.55%)) + (D(13.29b)/V(27.79b) * Rd(0.42%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 47.33 | Cagr: 0.47%
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 63.96% ; FCFE base≈1.08b ; Y1≈707.4m ; Y5≈323.5m
Fair Price DCF = 29.53 (DCF Value 5.04b / Shares Outstanding 170.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 31.47 | EPS CAGR: 12.17% | SUE: -0.98 | # QB: 0
Revenue Correlation: 90.00 | Revenue CAGR: 5.38% | SUE: N/A | # QB: None
Additional Sources for ARE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle